Aquatic Capital Management LLC Catalent, Inc. Transaction History

Aquatic Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $1.03 Million - $1.49 Million	32,100 New	32,100 $1.44 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $2.36 Million - $3.69 Million	32,600 Added 2037.5%	34,200 $2.48 Million
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $139,520 - $182,480	1,600 New	1,600 $172,000
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $28,257 - $37,347	-300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $35,871 - $41,721	300 New	300 $38,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.